This site is my collection of updates, statistics and analysis on intellectual property in Canada. I am a partner at DLA Piper (Canada) LLP practicing in the area of intellectual property (more about me). Material on this website are my own views and do not reflect the position of DLA Piper (Canada) LLP, any of its member firms around the world, or any of its clients. IPPractice.ca grew out of my hobby to gather and share interesting updates on intellectual property to friends and colleagues. Highlights include:
The US Supreme Court has found that the judges of the Patent Trial and Appeal Board (PTAB) were improperly appointed under the U.S. constitution but fixed the issue by making PTAB determinations reviewable by the director of the USPTO (see Arthrex).
The Federal Court of Appeal has issued another Practice Notice updating its COVID-19 related suspension periods including for files that were suspended in April (see earlier post) now that the “public health situation has now improved sufficiently”.
The new College of Patent Agents and Trademark Agents is coming into force on June 28, 2021. The College will regulate patent and trademark agents, including the exams, maintenance of the register of agents and disciplinary matters. …Read More
The various amendments relating to the Patented Medicines Prices Review Board mentioned in my update earlier this week have now been published in the Canada Gazette Part 2.
Various amendments relating to the Patented Medicines Prices Review Board are to come into force on June 30, 2021 including amendments to sections 79 to 103 of the Patent Act. In addition there are some changes being made for consistency with the Patent Act and to encompass CSPs. This is in addition to the amended Patented Medicines Regulations expanding reporting requirements are scheduled to come into force July 1, 2021 after being delayed several times. …Read More